OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The emerging role of noncoding RNAs in the PI3K/AKT/mTOR signalling pathway in breast cancer
Mohammed H. Abu-Alghayth, Farhan R. Khan, Tareg M. Belali, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155180-155180
Closed Access | Times Cited: 8
Mohammed H. Abu-Alghayth, Farhan R. Khan, Tareg M. Belali, et al.
Pathology - Research and Practice (2024) Vol. 255, pp. 155180-155180
Closed Access | Times Cited: 8
Showing 8 citing articles:
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials
Chen Zhang, Shu Xu, Chuanzheng Yin, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Chen Zhang, Shu Xu, Chuanzheng Yin, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Yu Mu, Haoxiang Liu, Anni Luo, et al.
Thoracic Cancer (2024) Vol. 15, Iss. 33, pp. 2356-2364
Open Access | Times Cited: 4
Optimizing selective estrogen receptor degraders for anticancer drug development
Neha Bhatia, Shashank Kumar, Lajya Devi Goyal, et al.
Future Medicinal Chemistry (2025), pp. 1-4
Closed Access
Neha Bhatia, Shashank Kumar, Lajya Devi Goyal, et al.
Future Medicinal Chemistry (2025), pp. 1-4
Closed Access
The Effect and Treatment of PIK3CA Mutations in Breast Cancer: Current Understanding and Future Directions
Young‐Bin Cho, Kyoung Sik Park
Medicina (2025) Vol. 61, Iss. 3, pp. 518-518
Open Access
Young‐Bin Cho, Kyoung Sik Park
Medicina (2025) Vol. 61, Iss. 3, pp. 518-518
Open Access
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts (Review)
Shaofeng Yang, Donghai Li
Oncology Letters (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 3
Shaofeng Yang, Donghai Li
Oncology Letters (2024) Vol. 28, Iss. 3
Open Access | Times Cited: 3
Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review
Zhiyong Long, Xiang Wang, Wei Xiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Zhiyong Long, Xiang Wang, Wei Xiao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
Weilin Shao, Yan Feng, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Weilin Shao, Yan Feng, Jin Huang, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential
Muqtada Shaikh, Gaurav Doshi
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1
Muqtada Shaikh, Gaurav Doshi
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1
